Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, Nantes, France.
Department of Diagnostic and Therapeutic Neuroradiology, Hôpital Foch Suresnes FR, University of Versailles Saint Quentin-en-Yvelines, Saint Quentin-en-Yvelines, France.
Eur Stroke J. 2023 Sep;8(3):655-666. doi: 10.1177/23969873231180338. Epub 2023 Jun 8.
Technical improvements in devices, changes in angiographic grading scales and various confounding factors have made difficult the detection of the temporal evolution of angiographic and clinical results after endovascular treatment (EVT) for acute ischemic Stroke (AIS). We analyzed this evolution in time using the Endovascular Treatment in Ischemic Stroke (ETIS) registry.
We analyzed the efficacy outcomes of EVT performed from January 2015 to January 2022, and modelized the temporal trends using mixed logistic regression models, further adjusted for age, intravenous thrombolysis prior to EVT, general anesthesia, occlusion site, balloon catheter use and the type of first-line EVT strategy. We assessed heterogeneity in temporal trends according to occlusion site, balloon catheter use, cardio embolic etiology, age (<80 years vs ⩾80 years) and first-line EVT strategy.
Among 6104 patients treated from 2015 to 2021, the rates of successful reperfusion (71.1%-89.6%) and of complete first pass effect (FPE) (4.6%-28.9%) increase, whereas the rates of patients with >3 EVT device passes (43.1%-17.5%) and favorable outcome (35.8%-28.9%) decrease significantly over time. A significant heterogeneity in temporal trends in successful reperfusion according to the first-line EVT strategy was found (p-het = 0.018). The temporal trend of increasing successful reperfusion rate was only significant in patients treated with contact aspiration in first-line (adjusted overall effect = 0.010).
In this 7-year-old large registry of ischemic stroke cases treated with EVT, we observed a significant increase with time in the rate of recanalization whereas there was a tendency toward a decrease in the rate of favorable outcome over the same period.
器械技术的改进、血管造影分级标准的变化以及各种混杂因素使得难以检测血管内治疗(EVT)后急性缺血性脑卒中(AIS)的血管造影和临床结果的时间演变。我们使用血管内治疗缺血性卒中(ETIS)登记处分析了这种时间演变。
我们分析了 2015 年 1 月至 2022 年 1 月期间进行的 EVT 的疗效结果,并使用混合逻辑回归模型对时间趋势进行建模,进一步根据年龄、EVT 前静脉溶栓、全身麻醉、闭塞部位、球囊导管使用以及一线 EVT 策略的类型进行调整。我们根据闭塞部位、球囊导管使用、心源性栓塞病因、年龄(<80 岁与 ⩾80 岁)和一线 EVT 策略评估时间趋势的异质性。
在 2015 年至 2021 年期间治疗的 6104 例患者中,再灌注成功(71.1%-89.6%)和完全首次通过效应(FPE)(4.6%-28.9%)的比例增加,而需要>3 次 EVT 器械通过(43.1%-17.5%)和良好结局(35.8%-28.9%)的比例显著降低。根据一线 EVT 策略,成功再灌注的时间趋势存在显著的异质性(p-het=0.018)。仅在一线使用接触抽吸治疗的患者中,再灌注成功率的时间趋势显著增加(调整后的总体效应=0.010)。
在这项为期 7 年的、采用 EVT 治疗的缺血性卒中大型登记研究中,我们观察到再通率随时间显著增加,而在同一时期,良好结局的比例呈下降趋势。